Is Diverticulitis a Functional Gastrointestinal Disorder?

Diverticulitis is not classified as a functional gastrointestinal disorder. It involves identifiable structural damage: small pouches (diverticula) that form in the colon wall and become inflamed or infected. Functional disorders, by contrast, are diagnosed when symptoms persist without a detectable structural or biochemical cause. That said, the boundary between diverticular disease and functional conditions like irritable bowel syndrome is far less clean than the classification suggests, and the two share enough biology and symptom overlap that researchers have spent the last two decades trying to figure out where one ends and the other begins.

What “Functional” Means in Gastroenterology

The term “functional gastrointestinal disorder” has been the standard label for conditions like IBS, functional dyspepsia, and functional constipation for decades, though the field has been moving away from it. The Rome IV criteria, the most widely used diagnostic framework, now prefer the term “disorders of gut-brain interaction” (DGBI), partly because “functional” carried an unhelpful implication that the symptoms were imaginary or purely psychological.

1PubMed Central. What Is New in Rome IV

DGBIs are grouped into symptom-based categories organized by the part of the gut they affect. The defining feature is that standard diagnostic tests don’t turn up a structural explanation for what the patient is experiencing.

2PubMed Central. Epidemiology of Disorders of the Gut-Brain Interaction: An Appraisal of the Rome IV Criteria and Beyond

Diverticulitis fails that definition on its face. You can see diverticula on a CT scan, and in an acute flare you can measure inflammation with blood markers and imaging. There is identifiable structural pathology, and that puts it firmly in the “organic disease” column by conventional classification.

The Spectrum of Diverticular Disease

Understanding why this question keeps coming up requires knowing that “diverticulitis” is just one point on a wider spectrum. Most people who develop diverticula never have symptoms at all. Roughly a quarter will eventually develop what doctors call symptomatic diverticular disease, and only about five percent experience an actual episode of acute diverticulitis with inflammation, fever, and the classic left-lower-abdominal pain.

3PubMed Central. Diverticular Disease: A Review on Pathophysiology and Recent Evidence

The middle category is where things get interesting. Symptomatic uncomplicated diverticular disease (SUDD) describes people who have diverticula and ongoing abdominal symptoms like cramping, bloating, and altered bowel habits, but without the acute inflammation that defines diverticulitis. SUDD has been described as “perhaps akin to irritable bowel syndrome,” which hints at why the functional-versus-structural question is so persistent.

4Gut and Liver. Diverticular Disease: An Update on Pathogenesis and Management

Why Symptoms Look So Similar to IBS

Both SUDD and IBS produce recurrent abdominal pain, bloating, and erratic bowel habits that swing between diarrhea and constipation. The symptom profiles overlap enough that clinicians sometimes struggle to tell them apart. Both conditions feature episodes that come and go, and both are worsened by stress and dietary factors. The main clinical difference that has been proposed is that SUDD symptoms tend to show up later in life, typically in the sixth or seventh decade, while IBS often presents much earlier.

5PubMed. Diverticular Disease and IBS: Overlapping or Misunderstanding?

One study that tried to find a distinguishing symptom looked at 42 patients with SUDD and 30 with IBS-like symptoms who happened to have diverticula. Severe, prolonged left-lower-abdominal pain lasting at least 24 consecutive hours was the best differentiator, pointing toward SUDD rather than IBS.

6Journal of Clinical Gastroenterology. Moderate to Severe and Prolonged Left Lower-abdominal Pain is the Best Symptom Characterizing Symptomatic Uncomplicated Diverticular Disease of the Colon

But even that finding has not been formally validated as a diagnostic rule, and in practice, many patients with diverticula and abdominal complaints occupy a gray zone between the two diagnoses. One review pointed out that both conditions feature recurrent pain episodes, though pain may be slightly more frequent in IBS, and both can involve diarrhea, constipation, or alternating patterns.

7PubMed. Is it diverticular disease or is it irritable bowel syndrome?

A Two-Way Street Between IBS and Diverticulitis

The overlap goes beyond symptom similarity. There is genuine biological traffic between the two conditions running in both directions. People who have an episode of acute diverticulitis are substantially more likely to develop IBS afterward. One study found that diverticulitis patients were roughly 4.7 times more likely to later receive an IBS diagnosis than matched controls, and about 2.4 times more likely to be diagnosed with any functional bowel disorder.

8PubMed Central. Increased risk for irritable bowel syndrome after acute diverticulitis

A Korean study that followed patients for about two and a half years after a diverticulitis episode found that roughly 13 percent developed IBS, compared to about 5 percent of controls. Among those who did develop post-diverticulitis IBS, diarrhea-predominant symptoms were most common.

9PubMed. Incidence and predictive factors of irritable bowel syndrome after acute diverticulitis in Korea

The relationship also runs in reverse. People with IBS appear to be at greater risk of developing acute diverticulitis. A population-based study found that the incidence of acute diverticulitis was nearly four times higher in people with IBS than in those without, and IBS was an independent risk factor for both developing diverticulitis and having it recur.

10PubMed. Increased incidence and recurrence rates of acute diverticulitis in patients with irritable bowel syndrome

Meanwhile, a separate population study found that people with IBS had about 1.8 times the odds of having diverticulosis. Among people 65 and older, IBS was associated with a ninefold higher likelihood of diverticula being present.

11PubMed Central. Diarrhea-predominant irritable bowel syndrome is associated with diverticular disease: a population-based study

This bidirectional pattern suggests the two conditions don’t just look alike on the surface. They share underlying biological pathways that can feed into each other.

Shared Biology Under the Surface

Several mechanisms that gastroenterologists associate with functional disorders also show up in diverticular disease, which is a big reason the neat classification breaks down.

Visceral hypersensitivity, where the gut’s nerves overreact to normal stimuli like stretching or pressure, is a hallmark of IBS. It also shows up in symptomatic diverticular disease. Research using balloon distension of the colon found that patients with SUDD reported pain at significantly lower pressure thresholds than asymptomatic people with diverticula, and they rated the same stimuli as more painful overall. The researchers linked this heightened sensitivity to low-grade inflammation and an increase in signaling molecules called tachykinins.

12PubMed. Visceral hypersensitivity in symptomatic diverticular disease and the role of neuropeptides and low grade inflammation

A separate study confirmed that perception of rectal and sigmoid colon distension was heightened in SUDD patients compared to healthy controls, even when the physical compliance of the bowel wall was the same across groups.

13PubMed Central. Colorectal visceral perception in diverticular disease

Low-grade inflammation also bridges the gap. Even after an acute flare resolves, people with symptomatic diverticular disease show persistent, smoldering inflammation that is too subtle to show up on standard imaging but detectable in tissue samples. This kind of inflammation is increasingly recognized in IBS as well, and in both conditions, it appears to sensitize the gut’s nerve endings and keep symptoms going.

14Hindawi / Mediators of Inflammation. Role of Inflammation in the Pathogenesis of Diverticular Disease

The enteric nervous system, the network of nerves embedded in the gut wall, also shows damage in diverticular disease that resembles what researchers find in functional conditions. In people with complicated diverticular disease, neurons show signs of stress and remodeling, and the interstitial cells of Cajal, which help coordinate gut contractions, lose their connections with surrounding tissue. Even in people with asymptomatic diverticula, these changes are present, just less severe.

15PubMed. Ultrastructural changes of the human enteric nervous system and interstitial cells of Cajal in diverticular disease

Biopsy studies of patients with symptomatic diverticular disease who had no visible inflammation on standard examination still showed elevated levels of multiple neuropeptides in the colon lining, a pattern the researchers interpreted as a footprint of prior inflammation that had technically resolved but left the nerve environment altered.

16PubMed. Post inflammatory damage to the enteric nervous system in diverticular disease and its relationship to symptoms

Gut motility is affected too. Colon muscle strips taken from SUDD patients showed reduced baseline tone and a weaker contractile response to stimulation compared to controls, suggesting that the motor machinery of the colon is impaired in ways that go beyond the mechanical distortion from diverticula themselves.

17PubMed Central. Impaired Colonic Contractility and Intestinal Permeability in Symptomatic Uncomplicated Diverticular Disease

Microbiome Disruptions

Another area of overlap involves the gut microbiome. Patients with diverticula, whether symptomatic or not, show a greater than 70 percent increase in colonic macrophages (immune cells) compared to healthy controls. Their stool samples also show a depletion of certain bacterial groups linked to gut health. Among symptomatic patients specifically, additional groups of beneficial bacteria were reduced compared to those who had diverticula but no symptoms.

18Gut. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease

More recent work has found that the microbiome of SUDD patients looks different depending on how severe their pain is. Those with mild pain tend to have more diverse microbial communities with a greater share of health-associated species, while those with severe pain have a microbial profile dominated by different bacterial families altogether.

19European Journal of Gastroenterology & Hepatology. Gut microbiota in symptomatic uncomplicated diverticular disease stratifies by severity of abdominal pain

This kind of pain-severity correlation mirrors findings in IBS research, where microbiome composition tracks with symptom burden, and adds another thread linking the two conditions at a mechanistic level.

The Gut-Brain Connection in Diverticular Disease

Functional disorders are increasingly understood through the gut-brain axis, the bidirectional communication network between the digestive system and the central nervous system. Diverticular disease fits into that framework more than you might expect from a supposedly “structural” condition. A large population study found that within five years of a diverticular disease diagnosis, about 14 percent of patients received a new diagnosis of depression (compared to about 11 percent of matched controls) and roughly 5 percent developed an anxiety disorder (compared to about 3 percent).

20PubMed Central. Diverticular disease is associated with an increased incidence rate of depression and anxiety disorders

Another study that examined predictors of recurrent pain in people with diverticulosis found that, alongside a history of acute diverticulitis, a raised score on a standard anxiety and depression scale was one of the best predictors of ongoing pain.

21British Journal of Surgery. Psychological and colonic factors in painful diverticulosis

Brain imaging research has explored this further. When anticipating a painful stimulus, patients with different forms of diverticular disease showed distinct patterns of brain activation and deactivation in regions involved in emotion processing, pain anticipation, and descending pain control. These patterns differed not just from healthy controls but also from IBS patients, suggesting that while diverticular disease engages the same gut-brain circuits, it does so in its own particular way.

22PubMed Central. Anticipation of thermal pain in diverticular disease

When Treatments Converge

One practical consequence of this biological overlap is that some treatments used for functional disorders are also effective in symptomatic diverticular disease. Rifaximin, a gut-targeted antibiotic that barely gets absorbed into the bloodstream, has become a mainstay of SUDD management. It is also used in IBS with diarrhea, reflecting the shared involvement of gut bacteria and low-grade inflammation in both conditions. Current evidence supports cyclical rifaximin use alongside a high-fiber diet as safe and effective for SUDD symptoms.

23PubMed Central. Diverticular Disease and Rifaximin: An Evidence-Based Review

Long-term data reinforces this. In one study following patients over eight years, those treated with rifaximin had substantially lower pain scores at the end of follow-up compared to those who were not, and they also experienced less bloating and fewer daily bowel movements. Rates of acute diverticulitis, surgery, and disease-related death were numerically lower in the rifaximin group, though those differences did not reach statistical significance.

24PubMed. Long-term efficacy of rifaximin to manage the symptomatic uncomplicated diverticular disease of the colon

A separate trial comparing rifaximin plus fiber to fiber alone over 24 months found a greater reduction in a composite symptom score and a lower probability of complications in the rifaximin group.

25PubMed Central. Efficacy of long term cyclic administration of the poorly absorbed antibiotic Rifaximin in symptomatic, uncomplicated colonic diverticular disease

Neuromodulators, drugs that alter how the nervous system processes pain signals, are another area of overlap. These medications are a standard treatment in functional disorders like IBS and functional abdominal pain. In a cohort of patients with chronic continuous abdominal pain, some of whom had diverticular disease, duloxetine was the most effective single agent, and combining neuromodulators outperformed using just one.

26PubMed. Chronic continuous abdominal pain: evaluation of diagnostic features, iatrogenesis and drug treatments in a cohort of 103 patients

Dietary strategies also cross the divide. A low-FODMAP diet, which restricts certain fermentable carbohydrates, is a well-established intervention for IBS. Researchers have proposed that the same approach could help prevent diverticulitis recurrence by reducing gas production and colonic pressure, though direct trial evidence for this specific application is still lacking.

27PubMed Central. Logical hypothesis: Low FODMAP diet to prevent diverticulitis

A Practical Diagnostic Tool

Given how much the symptoms overlap, clinicians need objective ways to distinguish SUDD from IBS in patients who have diverticula. Fecal calprotectin, a protein released by inflamed gut tissue and measured through a simple stool test, is one candidate. It is already used to differentiate IBS from inflammatory bowel disease. In the context of diverticular disease, one study found that fecal calprotectin had a sensitivity of about 95 percent for identifying patients with SUDD, though its specificity was only around 44 percent, meaning it catches most SUDD cases but also flags many people who don’t have it.

28Medicina Clínica (English Edition). Utility of fecal calprotectin in the follow-up of uncomplicated acute diverticulitis

That combination of high sensitivity and modest specificity is useful in one particular way: a low calprotectin result makes SUDD unlikely and tilts the diagnosis toward a functional disorder. In practice, it works better as a rule-out test than a rule-in test. An elevated result still needs interpretation in the full clinical picture, including age, symptom timing, and imaging findings.

Why the Classification Matters Less Than You Think

For patients living with persistent symptoms, whether their condition gets stamped “structural” or “functional” can feel like an academic debate. But the label has real consequences. Insurance coverage, referral pathways, and which treatments a clinician considers all depend on how the condition is framed. Patients told they have a “functional” problem sometimes feel dismissed; patients told they have diverticular disease may receive more aggressive interventions than their symptoms warrant.

The emerging picture from research is that symptomatic diverticular disease occupies territory that does not fit neatly into either box. It has structural pathology you can point to on a scan, but the mechanisms driving ongoing symptoms, visceral hypersensitivity, nerve remodeling, microbiome changes, and gut-brain axis disruption, are the same ones driving functional conditions. When acute diverticulitis resolves but symptoms persist, the biology keeping those symptoms alive looks remarkably similar to what happens in IBS. The formal classification remains clear: diverticulitis is not a functional disorder. The biology is less cooperative with that boundary than the textbooks would like.